Nagercoil Diagnostics Private Limited
About Nagercoil Diagnostics Private Limited
Data last updated:
Nagercoil Diagnostics Private Limited is a private limited company based in Nagercoil, Tamil Nadu, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 12 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2012PTC083979.
The company has an authorised share capital of ₹2.15 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors including Jeyaharan Sunil J Jeyaharan (Managing Director) and Thanumalayaperumal Thiraviam (Director Appointed In Casual Vacancy).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 265 – 266 M.S. Road Krishnankoil, Nagercoil, Tamil Nadu, India – 629001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.63 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹27.68 Lakh (net margin -7.6%) and EBITDA of ₹3.28 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.76 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nagercoil Diagnostics Private Limited's registered office is in Nagercoil, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address265 – 266 M.S. Road Krishnankoil, Nagercoil, Tamil Nadu, India – 629001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Nagercoil Diagnostics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nagercoil Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Nagercoil Diagnostics Private Limited, buy the company report.
Financials of Nagercoil Diagnostics Private Limited
FY 2025 filings availableNagercoil Diagnostics Private Limited reported revenue of ₹3.63 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹27.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nagercoil Diagnostics Private Limited, buy the company report.
Board of directors of Nagercoil Diagnostics Private Limited
Nagercoil Diagnostics has 7 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thanumalayaperumal Thiraviam Also directs: Apple Bio Medics Limited | Director Appointed In Casual Vacancy | 31 Aug 2015 | 11 Years 1 Months | Current |
| Mohandhas Badri Ramnath Also directs: Sushrushah Medicare Centre Private Limited | Director Appointed In Casual Vacancy | 31 Aug 2015 | 11 Years 1 Months | Current |
| Jaya Gauthaman | Director Appointed In Casual Vacancy | 31 Aug 2015 | 11 Years 1 Months | Current |
| Muthuretnam Thiagarajan | Director Appointed In Casual Vacancy | 31 Aug 2015 | 11 Years 1 Months | Current |
| Ramasamy Mohandhas | Director | 12 Jan 2012 | 14 Years 9 Months | Current |
| Jeyaharan Sunil J Jeyaharan Also directs: Nagercoil Stone Clinic Private Limited | Managing Director | 12 Jan 2012 | 14 Years 9 Months | Current |
Peer comparison
Nagercoil Diagnostics Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Centogene India Private Limited | ₹3.64 Cr (FY 2025) | 4.0% | Delhi, India | |||
| Pro Plus Diagnostic Private Limited | ₹3.63 Cr (FY 2025) | 7.0% | Cuttack, Odisha, India | |||
| Nagercoil Diagnostics Private Limitedthis company | ₹3.63 Cr (FY 2025) | -₹27.68 Lakh | -7.6% | -5.0% | 12 | Nagercoil, Tamil Nadu, India |
| Nobelcure Healthcare Private Limited | ₹3.6 Cr (FY 2025) | 45.0% | Jodhpur, Rajasthan, India | |||
| Kalji Diagnosis Center Private Limited | ₹3.6 Cr (FY 2024) | 85.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Nagercoil Diagnostics Private Limited, buy the company report.
Auditor
Nagercoil Diagnostics Private Limited is audited by B. THANU PILLAI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. THANU PILLAI & CO | FY 2023 | 004363S |
Shareholding
The shareholding of Nagercoil Diagnostics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nagercoil Diagnostics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Aug 2016 | 100068228 | Others | ₹7.16 Cr | Open | |
| 23 Mar 2016 | 100018958 | Others | ₹60 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Nagercoil Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nagercoil Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nagercoil Diagnostics Private Limited has a workforce of 12 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Nagercoil Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nagercoil Diagnostics Private Limited has 13 board changes on record since 2012: 7 appointments and 6 cessations. The latest: Chandrakasan Gauthaman ceased to be Managing Director on 09 Nov 2018.
6 earlier events are in the company report.
Frequently asked questions
Nagercoil Diagnostics is an active private limited company based in Nagercoil, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 12 January 2012 (14+ years old) and is registered under CIN U74900TN2012PTC083979.
Nagercoil Diagnostics has 7 current directors:
- Jeyaharan Sunil J Jeyaharan - Managing Director
- Thanumalayaperumal Thiraviam - Director Appointed In Casual Vacancy
- Mohandhas Badri Ramnath - Director Appointed In Casual Vacancy
- Jaya Gauthaman - Director Appointed In Casual Vacancy
- Muthuretnam Thiagarajan - Director Appointed In Casual Vacancy
- Ramasamy Mohandhas - Director
- Chandrakasan Gauthaman - Director
The latest financial statements of Nagercoil Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nagercoil Diagnostics is U74900TN2012PTC083979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nagercoil Diagnostics was incorporated on 12 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Nagercoil Diagnostics by revenue are Centogene India Private Limited, Pro Plus Diagnostic Private Limited, Nobelcure Healthcare Private Limited, Kalji Diagnosis Center Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Chandrakasan Gauthaman ceased to be Managing Director on 09 Nov 2018. Jeyaharan Sunil J Jeyaharan ceased to be Director on 09 Nov 2018. Ganesa Pillai Anandakumar ceased to be Director on 31 Aug 2015. Nagercoil Diagnostics has 13 board changes on record in total.
The registered office of Nagercoil Diagnostics is at 265 – 266 M.S. Road Krishnankoil, Nagercoil, Tamil Nadu, India – 629001.
Nagercoil Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Nagercoil Diagnostics has open charges of ₹7.76 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Nagercoil Diagnostics is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.